Moleculin Biotech Inc (MBRX)

CUSIP: 60855D408 | NYSE | 29 institutional holders

Compare Detailed Historical Funds Options Short Interest 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13DKlemp Walter V with AnnaMed, Inc.	2,070,761	9.9%	New 5%+ stake	Aug 19, 2026	No 13F filer matched
13DFoster Jonathan P.	1,288,207	6.3%	New 5%+ stake

Institutional Holders — Q3 2026

Sort by

Geode Capital Management, LLC104,670

0.0% of portfolio$52.4K

Deutsche Bank Ag\1,000

0.0% of portfolio$500

Nfsg Corp114

0.0% of portfolio$57

Danske Bank A/S2

0.0% of portfolio$1

Caitong International Asset Management Co., Ltd1

0.0% of portfolio$0

				Style	Turnover	Location	Filed
Geode Capital Management, LLC	104,670	$52.4K	0.0%	Index	Very Low	Boston, MA	2026-11-06
Deutsche Bank Ag\	1,000	$500	0.0%	Core	Low	Frankfurt Am Main, Hong Kong	2026-11-06
Nfsg Corp	114	$57	0.0%	Growth	Medium	Boca Raton, FL	2026-10-15
Danske Bank A/S	2	$1	0.0%	Growth	Low	Copenhagen V, Greece	2026-11-09
Caitong International Asset Management Co., Ltd	1	$0	0.0%	Growth	Very High	Hong Kong, South Korea	2026-10-29

13DKlemp Walter V2,070,761

9.9% of class · Aug 19, 2026New 5%+ stake

with AnnaMed, Inc.

No 13F filer matched

13DFoster Jonathan P.1,288,207

6.3% of class · Aug 19, 2026New 5%+ stake

No 13F filer matched

13GCVI Investments, Inc.1,863,377

9.9% of class · Jul 31, 2026New 5%+ stake

No 13F filer matched

13GIntracoastal Capital LLC973,927

5.0% of class · Jul 31, 2026Newly reported

No 13F filer matched